Professional Essentials

  • US Professional News
  • FULLTEXT

Patients have many reasons to avoid care

  • US Professional News
  • FULLTEXT

Physicians should get political, MD argues

  • US Professional News
  • FULLTEXT

CMS primary care reimbursement improving

  • US Professional News
  • FULLTEXT

Surgeon general's brother a cautionary tale

  • Patients Will Be Asking

Patients Will Be Asking: Does the birth control pill cause cancer?

  • US Professional News
  • FULLTEXT

Surgeon took Spanish exam on his cellphone during operation: lawsuit

View more

New on Univadis

  • Clinical Essentials from JAMA Oncology
  • 1 comment
  • FULLTEXT

Ovarian cancer: multimodal screening may be cost-effective in the US

Markov model was based on data from the UKCOCS trial.

Primary Care Oncology Vitals for December 2017
  • Vitals
  • no comment

Primary Care Oncology Vitals for December 2017

Enrollment expansion for 4 cancer types in TAPUR study | Breast cancer can re-emerge 20 years later | Intermittent letrozole in breast cancer | Implications of negative screening results history.

  • Clinical Essentials from Osteoporos Int
  • 1 comment

Women with osteoporosis often have lung problems, as well

Study finds association between lower BMD and reduced pulmonary function.

  • Clinical Essentials from Obstet Gynecol
  • no comment

Ob-gyns prescribing excessive opioids, study finds

Results of a nationwide survey.

  • Clinical Essentials from JAMA Cardiol
  • 1 comment

NBA players have unexpectedly high rate of abnormal ECG findings

T-wave inversions are the most common abnormality.

  • Clinical Essentials from JAMA Otolaryngol Head Neck Surg
  • 1 comment

Age-related hearing loss may be modifiable risk factor for dementia

A meta-analysis of 36 studies among roughly 20,000 individuals.

  • Clinical Essentials from Arthritis Res Ther
  • 1 comment
  • FULLTEXT

Ankylosing spondylitis: proper site to measure BMD loss identified

Patients with AS are more likely to suffer osteoporosis.

  • The ASCO Post
  • 1 comment

SABCS 2017: MONALEESA-7: Ribociclib Improved Progression-Free Survival for Pre- and Perimenopausal Women With HR-Positive Advanced Breast Cancer

Adding ribociclib to standard endocrine therapy with temporary ovarian suppression significantly improved progression-free survival for pre- and perimenopausal women with advanced hormone receptor (HR)-positive, HER2-negative breast cancer, according to data from the MONALEESA-7 trial presented by Tripathy et al.

  • The ASCO Post
  • 1 comment

SABCS 2017: Acupuncture May Reduce Joint Pain Caused by Aromatase Inhibitor Treatment

Acupuncture significantly reduced joint pain for postmenopausal women with early-stage breast cancer receiving treatment with an aromatase inhibitor compared with both sham acupuncture and no treatment, according to data from the randomized, phase III SWOG S1200 trial presented by Hershman et al.

  • The ASCO Post
  • 1 comment

SABCS 2017: Combination of Pembrolizumab and Trastuzumab Shows Early Promise for Patients With Trastuzumab-Resistant Breast Cancer

A combination of pembrolizumab and trastuzumab tested in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well tolerated and had clinical benefit in patients whose tumors were positive for a biomarker for pembrolizumab, according to data presented from the phase Ib/II PANACEA trial by Loi et al.

  • Clinical Essentials from Clin Transplant
  • 1 comment

Post-LT HCV: extended DCV+SOF±RBV delivers high SVR12

Multicenter Italian study of patients with severe fibrosis, cirrhosis.

  • Clinical Essentials from Diabetes Care
  • 1 comment
  • FULLTEXT

New diabetes care standards include explicit recommendations for patients with cardiovascular disease

Evidence-based recommendations cover many aspects of diabetes screening, prevention, and care.

  • Clinical Essentials from JAMA Oncol
  • 1 comment

mCRPC: enzalutamide safe in patients with seizure risk

UPWARD study evaluated patients at high risk for seizures.

  • Clinical Essentials from Br J Oral Maxillofac Surg
  • no comment

Oral SCC: new AJCC staging guidelines offer more accurate prognosis

Eighth edition provides improved discrimination for disease-specific survival.